Profil
Kate E.
Broderick is Senior Vice President-Research & Development at TriLink BioTechnologies LLC since 2022.
Formerly, Dr. Broderick was Senior Vice President-Research & Development at Inovio Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Broderick was Chief Innovation Officer at Maravai Lifesciences Holdings, Inc. from 2022 to 2025.
Dr. Broderick earned a doctorate from the University of Glasgow.
Aktive Positionen von Kate Broderick
| Unternehmen | Position | Beginn |
|---|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Ehemalige bekannte Positionen von Kate Broderick
| Unternehmen | Position | Ende |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2025 |
| INOVIO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2022 |
Ausbildung von Kate Broderick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Commercial Services |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Maravai Lifesciences Holdings, Inc.
Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
















